The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tissue Evaluation: Understanding Rheumatoid Arthritis Inside & Out

Tissue Evaluation: Understanding Rheumatoid Arthritis Inside & Out

March 23, 2022 • By Jason Liebowitz, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

BALTIMORE—One of the greatest advancements in medicine in the past generation has been the ability to examine disease pathogenesis, response to treatment and other issues at the most minuscule level, including that of single cells. At the 17th Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases meeting at Johns Hopkins University School of Medicine, Baltimore, Clifton O. “Bing” Bingham III, MD, professor of medicine and director of the Arthritis Center at Johns Hopkins School of Medicine, provided a masterful overview of rheumatoid arthritis (RA) with this perspective in mind.

You Might Also Like
  • Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes
  • Understanding the Role of Citrullination in Rheumatoid Arthritis
  • Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis
Explore This Issue
April 2022
Also By This Author
  • Bloody Important: Atherosclerosis & Thrombotic Disease in Rheumatic Conditions

Synovial Tissue Biopsy

An expanded understanding of the pathogenesis of RA is one of the most exciting, cutting-edge areas within rheumatology, Dr. Bingham stated. The Accelerating Medicines Partnership (AMP), a collaborative effort of the National Institutes of Health, the U.S. Food & Drug Administration, and multiple biopharmaceutical and life science companies and non-profit organizations, has the goal of transforming the current model for developing new diagnostics and treatments. One AMP initiative is looking at synovial tissue biopsy in patients with RA to better understand what is happening in these patients at the tissue level.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As a first step in these projects, synovial tissue acquired from patients subsequently undergoes disaggregation. While a sample of the tissue is examined using standard histology, other cells are separated and analyzed, some using flow cytometry and others using mass cytometry. After these cells are sorted into individual populations, they are then subjected to certain forms of analysis that allow the evaluation of RNA sequencing, which can be done both on bulk samples as well as on single-cell sorted samples.

The tissues are then grouped as patients with leukocyte-rich rheumatoid arthritis and a great deal of infiltrating cells present in tissue, and those with leukocyte-poor RA. As a means of comparison, synovial tissue samples from patients with osteoarthritis are also evaluated. These different data sets are then mined using advanced analytical methods to begin to look at what is happening at the single cell level.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Even at this early stage of discovery, interesting insights are being revealed about RA. For example, sublining fibroblasts are highly expressed in RA synovium, whereas lining fibroblasts are more common in osteoarthritis synovium.1 These sublining fibroblasts in RA patients are particularly expressive of interleukin (IL) 6. In contrast, pro-inflammatory myocytes in the synovium of patients with RA produce primarily IL-1.

Populations of autoimmune B cells have been identified in synovial tissue, and T cells (specifically peripheral helper and follicular helper T cells) have also been identified. Among T cells, distinct subsets of CD8+ T cells have been discovered, many of which were not previously known.1 Dr. Bingham noted that all of these data are giving more information about what is happening in the synovial microenvironment in terms of the numbers and types of cells, what they are expressing and where they are located.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: Advances in the Diagnosis and Treatment of the Rheumatic Diseases meeting, biopsy, macrophages, RA Resource Center, Rheumatoid Arthritis (RA)Issue: April 2022

You Might Also Like:
  • Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes
  • Understanding the Role of Citrullination in Rheumatoid Arthritis
  • Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis
  • The Role of Autoreactive B Cells in Rheumatoid Arthritis

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)